CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding CymaBay Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 118 | 4 | 106 | −8 |
| Shares | 65.2M | 423.7K | 63.0M | −1.78M (−2.7%) |
| Value | $202.8M | $1.32M | $185.9M | −$15.6M (−7.8%) |
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 1,575,269 | $4.65M | 0.19% |
| Ergoteles LLC | 410,400 | $1.21M | 0.04% |
| Point72 Asset Management, L.P. | 350,000 | $1.03M | 0.00% |
| Pinz Capital Management, LP | 231,680 | $683.0K | 0.47% |
| Acadian Asset Management LLC | 31,827 | $94.0K | 0.00% |
| LMR Partners LLP | 30,360 | $90.0K | 0.00% |
| Myriad Asset Management US LP | 30,000 | $89.0K | 0.02% |
| Y-Intercept (Hong Kong) Ltd | 23,644 | $70.0K | 0.01% |
| Qube Research & Technologies Ltd | 18,162 | $54.0K | 0.00% |
| Verition Fund Management LLC | 15,800 | $47.0K | 0.00% |
| Boothbay Fund Management, LLC | 14,479 | $43.0K | 0.00% |
| Jane Street Group, LLC | 12,252 | $36.0K | 0.00% |
| Marshall Wace, LLP | 11,000 | $33.0K | 0.00% |
| LVM Capital Management Ltd | 10,000 | $30.0K | 0.00% |
| Vectors Research Management, LLC | 6,000 | $18.0K | 0.00% |
| EverSource Wealth Advisors, LLC | 1,702 | $5.00K | 0.00% |
| Truvestments Capital LLC | 1,487 | $4.00K | 0.00% |
| Howe & Rusling Inc | 200 | $1.00K | 0.00% |
| Massmutual Trust Co FSB | 288 | $1.00K | 0.00% |
| Glassman Wealth Services | 1 | $0 | 0.00% |
Sold out (28)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (4)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 334,713 | $1.04M |
| Golden State Equity Partners | 50,600 | $157.0K |
| Myriad Asset Management Ltd. | 30,000 | $93.0K |
| Amalgamated Financial Corp. | 8,381 | $26.0K |